V Wealth Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

V Wealth Advisors’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-518	Closed	-$245K	–	477
2021 Q1	$245K	Sell	518 -5	-1%	-$2.43K	0.05%	369
2020 Q4	$253K	Buy	+523	New	+$282K	0.05%	330
2020 Q3	–	Sell	-511	Closed	-$318K	–	302
2020 Q2	$318K	Sell	511 -20	-4%	-$11.4K	0.08%	260
2020 Q1	$259K	Buy	+531	New	+$219K	0.08%	250
2017 Q3	–	Sell	-15	Closed	-$7K	–	590
2017 Q2	$7K	Buy	+15	New	+$6.56K	﹤0.01%	622

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

V Wealth Advisors's REGN Position: Q2 2021 in Review

V Wealth Advisors sold out of Regeneron Pharmaceuticals (REGN) in Q2 2021, closing a stake of 518 shares — an estimated $245K sold.

V Wealth Advisors first reported a position in REGN in Q2 2017 and held it in 5 quarters. The position peaked at $318K in Q2 2020. 971 funds tracked by Wall St. Rank hold REGN as of Q2 2021.

V Wealth Advisors reported no remaining Regeneron Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
V Wealth Advisors sold 518 Regeneron Pharmaceuticals shares in Q2 2021, an estimated $245K.
V Wealth Advisors first reported a position in Regeneron Pharmaceuticals in Q2 2017 and held it in 5 quarters.
V Wealth Advisors's Regeneron Pharmaceuticals position peaked at $318K in Q2 2020.
971 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2021.

Based on V Wealth Advisors's 13F filing for Q2 2021, filed 27 Jul 2021.